NDC 63187-526 – Ondansetron

Ondansetron 4 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC63187-526

Product details

Brand name
Ondansetron
Generic name
Ondansetron
Labeler
Proficient Rx LP
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
ANDA · ANDA090469
Marketed since
April 12, 2010
Listing expires
December 31, 2026
Pharmacologic class
Serotonin-3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ondansetron →

Package NDC codes (9)

Package NDCDescriptionSince
63187-526-033 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63187-526-03)Feb 1, 2019
63187-526-044 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63187-526-04)Nov 25, 2019
63187-526-055 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63187-526-05)Apr 1, 2019
63187-526-066 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63187-526-06)Aug 1, 2019
63187-526-1010 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63187-526-10)Aug 3, 2015
63187-526-1212 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63187-526-12)Jun 20, 2023
63187-526-1515 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63187-526-15)Aug 1, 2016
63187-526-2020 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63187-526-20)Mar 1, 2019
63187-526-3030 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63187-526-30)Aug 3, 2015

Other Ondansetron products